3,589 Shares in VanEck Pharmaceutical ETF (NASDAQ:PPH) Purchased by Grimes & Company Inc.

Grimes & Company Inc. acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,589 shares of the company’s stock, valued at approximately $310,000.

Other hedge funds have also added to or reduced their stakes in the company. FMR LLC boosted its holdings in VanEck Pharmaceutical ETF by 12.5% in the 3rd quarter. FMR LLC now owns 1,905 shares of the company’s stock worth $181,000 after buying an additional 212 shares during the period. Edge Financial Advisors LLC bought a new position in shares of VanEck Pharmaceutical ETF in the third quarter worth $263,000. Harbour Investments Inc. grew its position in shares of VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock valued at $325,000 after purchasing an additional 488 shares in the last quarter. Townsquare Capital LLC grew its position in shares of VanEck Pharmaceutical ETF by 3.8% in the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after purchasing an additional 130 shares in the last quarter. Finally, Assetmark Inc. raised its stake in shares of VanEck Pharmaceutical ETF by 5.8% during the 3rd quarter. Assetmark Inc. now owns 6,491 shares of the company’s stock valued at $617,000 after purchasing an additional 354 shares during the period.

VanEck Pharmaceutical ETF Stock Up 1.0 %

PPH stock opened at $87.71 on Monday. The stock has a 50-day simple moving average of $87.64 and a two-hundred day simple moving average of $91.96. VanEck Pharmaceutical ETF has a twelve month low of $83.74 and a twelve month high of $99.51. The firm has a market capitalization of $573.62 million, a PE ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were paid a $0.411 dividend. The ex-dividend date was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.